⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 23, 2024Bioactive MaterialsOpen Access

A scaffold vaccine to promote tumor antigen cross-presentation via sustained toll-like receptor-2 (TLR2) activation

Daping Xie Congwei Han Chonghao Chen Zhencheng Liao Senio Campos de Souza Yiming Niu João F. Mano Lei Dong Chunming Wang

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Cancer vaccination holds great promise for cancer treatment, but its effectiveness is hindered by suboptimal activation of CD8

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Xie et al. (2024) studied this question.

synapsesocial.com/papers/68e6df92b6db64358765af3d https://doi.org/10.1016/j.bioactmat.2024.03.035

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Synthetic Cathepsin B Sensitive Adjuvant‐Peptide Conjugates to Target Intracellular Toll‐Like Receptors 7 and 82025
2Spatiotemporally engineered tumor-derived extracellular vesicle-based scaffold vaccine for personalized cancer immunotherapyOriginal Research · 2026 · 7 citations
3Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapyClinical Trial · 2023 · 95 citations
4Increasing the Antigenicity of Synthetic Tumor‐Associated Carbohydrate Antigens by Targeting Toll‐Like ReceptorsOriginal Research · 2009 · 99 citations
5Dibenzocyclooctyne Conjugation Enhances Antigen Cross-Presentation and T-Cell Killing for Potent Cancer VaccinesOriginal Research · 2026
6A general pHLA-CD80 scaffold fusion protein to promote efficient antigen-specific T-cell-based immunotherapy2024 · 1 citations
7Designing a tumor landscape-modifying vaccine with a unique TLR2/6 agonist for refractory pancreatic cancerOriginal Research · 2026
8Vaccination with DC-SIGN-Targeting αGC Liposomes Leads to Tumor Control, Irrespective of Suboptimally Activated T-Cells2024 · 5 citations
9A fluorinated poly(amino acid) nanovaccine with spatiotemporally encoded innate priming and antigen cross-presentation for tumor immunotherapyBioactive Materials · 2026
10Sustained delivery of 3D-bioprinted stem cell-derived small extracellular vesicles promotes neural regeneration following traumatic brain injury via the CREB1/PGC-1α/FNDC5 axisBioactive Materials · 2026

More from Bioactive Materials

More from Nanjing University

More from University of Aveiro

More from University of Macau